COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01583478
Recruitment Status : Unknown
Verified September 2014 by Corey S. Maas, M.D., The Maas Clinic.
Recruitment status was:  Recruiting
First Posted : April 24, 2012
Last Update Posted : September 30, 2014
Merz North America, Inc.
Information provided by (Responsible Party):
Corey S. Maas, M.D., The Maas Clinic

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2015
Estimated Study Completion Date : December 2015